Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Acapodene reduces high-grade prostate intraepithelial neoplasia in phase II study

July 2, 2003

Four new trials expand evaluation of Genasense

July 1, 2003

Onyx prioritizes Bay-43-9006 program, discontinues therapeutic virus program

July 1, 2003

New urokinase inhibitors under study at Corvas

July 1, 2003

AstraZeneca claims new IGF-1R modulators with utility in cancer therapy

July 1, 2003

Aventis develops new tubulin polymerization inhibitors

July 1, 2003

Wilex radioimmunotherapy enters clinical evaluation in biliary cancers

July 1, 2003

Introgen and NCI enter CTA for development of Advexin

July 1, 2003

Apoptosis inducers prepared and tested at the Burnham Institute

June 30, 2003

Antitumor epothilones identified by Kosan scientists

June 30, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...
Recombinant vaccine inhibits HBV-associated HCC growth
BioWorld Science
Chronic liver disease and hepatocellular carcinoma (HCC) associated with chronic hepatitis B virus (HBV) are serious health problems in highly endemic areas....